LAMP5 expression effectively predicted the infrequent gene fusion KMT2A-USP2, frequently overlooked by routine methods, and the resultant gene product may serve as a viable therapeutic target in KMT2A-r leukemia. The gene discussed is KMT2A; the disease is leukemia.